Status:
RECRUITING
Type 2 Continuous Glucose Monitoring Academy
Lead Sponsor:
Children's Hospital Los Angeles
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
8-21 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D): ...
Eligibility Criteria
Inclusion
- Current age of 8-21 years;
- T2D diagnosis;
- Able to speak, read, and write English or Spanish
Exclusion
- a. Known history of medical adhesive allergies;
Key Trial Info
Start Date :
June 23 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06516640
Start Date
June 23 2025
End Date
December 30 2026
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027